PTPN2 and cancer: Furthermore, a correlation between PTPN2 transcript levels and immunosuppressive cells, such as neutrophils, MDSCs, and Tregs, was observed, with neutrophils [36, 37], MDSCs [38], and Tregs [39] exhibiting strong immunosuppressive activities and contributing to poor clinical outcomes in patients with cancers.